ESC 365 - New ESC 2021 Guidelines Heart Failure & Valvular Heart Disease : what changed.

Open Access

New ESC 2021 Guidelines Heart Failure & Valvular Heart Disease : what changed.

Session: Elevating the standard of valvular heart therapies: key role of the echocardiologist

Topic: Valvular Heart Disease

Speaker: Doctor M. Senni (Bergamo, IT)

Sponsored by Abbott Structural Heart

Event: EuroEcho 2021

Congress Presentation

About the speaker

Doctor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)

37 presentations

0 follower

6 more presentations in this session

Introduction.

Speaker: Doctor M. Sitges (Barcelona, ES)

Tailoring Transcatheter Mitral Regurgitation Treatment : the evidence.

Speaker: Professor R. Von Bardeleben (Mainz, DE)

Tailoring Transcatheter Mitral Regurgitation Treatment : the Patient.

Speaker: Doctor M. Swaans (Nieuwegein, NL)

Diagnostic and therapeutic Advances to Optimize Tricuspid Regurgitation management : the evidence.

Speaker: Assistant Professor M. Taramasso (Zurich, CH)

Diagnostic and therapeutic Advances to Optimize Tricuspid Regurgitation management : the Patient.

Speaker: Doctor M. Swaans (Nieuwegein, NL)

Access the full session

Elevating the standard of valvular heart therapies: key role of the echocardiologist

Speakers: Doctor M. Senni, Doctor M. Sitges, Professor R. Von Bardeleben, Doctor M. Swaans, Assistant Professor M. Taramasso...

About the event

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Congress

Related content

EHRA Premium Access

Hot topics in atrial fibrillation.

5 April 2022

ACVC Premium Access

Management of acute pericarditis refractory to first-line treatments.

19 March 2022

Open Access

Cancer and heart interactions: from prevention to long-term management

27 August 2021

ESC 365 is supported by